Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JOHN MEADOWS

Allopathic & Osteopathic Physicians Allergy & Immunology Allergy

NPI
1811952849
CMS profile
37032
Location
BIRMINGHAM, AL

General Payments · PY2018–2024

$246,810.23

  • Reported across 687 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$10,363.33

25 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $44,144.33 128
PY2019 $23,113.24 81
PY2020 $17,630.99 97
PY2021 $40,680.08 124
PY2022 $62,748.12 152
PY2023 $48,130.14 80
PY2024 $10,363.33 25

Payment records · PY2024 (25)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $121.02 05/31/2024 Food and Beverage Undisputed 01/23/2026 1104718627 CMS
AstraZeneca Pharmaceuticals LP $64.20 06/01/2024 Food and Beverage Undisputed 01/23/2026 1104268569 CMS
AstraZeneca Pharmaceuticals LP $121.84 10/29/2024 Food and Beverage Undisputed 01/23/2026 1104668489 CMS
CSL Behring $34.03 08/02/2024 Food and Beverage Undisputed 01/23/2026 1134600631 CMS
Genentech USA, Inc. $51.30 05/17/2024 Food and Beverage Undisputed 01/23/2026 1133035622 CMS
GENZYME CORPORATION $29.73 02/23/2024 Food and Beverage Undisputed 01/23/2026 1139843595 CMS
GENZYME CORPORATION $39.38 05/31/2024 Food and Beverage Undisputed 01/23/2026 1139843619 CMS
GENZYME CORPORATION $22.87 10/08/2024 Food and Beverage Undisputed 01/23/2026 1139843715 CMS
GENZYME CORPORATION $126.62 10/25/2024 Food and Beverage Undisputed 01/23/2026 1139843699 CMS
GENZYME CORPORATION $110.32 10/26/2024 Food and Beverage Undisputed 01/23/2026 1139843697 CMS
GlaxoSmithKline, LLC. $28.53 10/18/2024 Food and Beverage Undisputed 01/23/2026 1116662347 CMS
Greer Laboratories, Inc. $25.22 10/25/2024 Food and Beverage Undisputed 01/23/2026 1131113427 CMS
Melinta Therapeutics, LLC $18.06 10/03/2024 Food and Beverage Undisputed 01/23/2026 1140481646 CMS
Novartis Pharmaceuticals Corporation $2,012.50 06/01/2024 Consulting Fee Undisputed 01/23/2026 1086983510 CMS
Novartis Pharmaceuticals Corporation $134.64 06/01/2024 Food and Beverage Undisputed 01/23/2026 1086983518 CMS
Regeneron Healthcare Solutions, Inc. $2,446.50 04/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1114112779 CMS
Regeneron Healthcare Solutions, Inc. $1,342.08 05/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1114112781 CMS
Regeneron Healthcare Solutions, Inc. $55.88 06/03/2024 Food and Beverage Undisputed 01/23/2026 1114112783 CMS
Regeneron Pharmaceuticals, Inc. $89.37 10/26/2024 Food and Beverage Undisputed 01/23/2026 1114402585 CMS
Takeda Pharmaceuticals U.S.A., Inc. $66.83 02/08/2024 Food and Beverage Undisputed 01/23/2026 1137633764 CMS
Takeda Pharmaceuticals U.S.A., Inc. $12.79 05/30/2024 Food and Beverage Undisputed 01/23/2026 1137633766 CMS
Takeda Pharmaceuticals U.S.A., Inc. $98.31 05/30/2024 Food and Beverage Undisputed 01/23/2026 1137633768 CMS
Takeda Pharmaceuticals U.S.A., Inc. $50.16 05/30/2024 Food and Beverage Undisputed 01/23/2026 1137633770 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,860.00 07/01/2024 Consulting Fee Undisputed 01/23/2026 1137633772 CMS
Takeda Pharmaceuticals U.S.A., Inc. $401.15 07/08/2024 Travel and Lodging Undisputed 01/23/2026 1137633774 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.